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RV+' RV-' P value
7219C OFT 66 ± 31 J 108 ± 55J 0007
Impedance 59.3 ± 88 Q 603±7.0Q 0.33
72190 OFT 12.0 ± 4.0 J 163±7.3J 0.07
Impedance 50.5 ± 67 Q 475 ± 8.9 Q 0.23
The effect of the polarity of the initial phase of a biphasic shock waveform
on the defibrillation threshold (DFT) of cardioverter-defibrillators (I CDs) is not
known. We tested this in two investigational pectorally implanted biphasic
ICDs - Medtronic Models 7219C and 7219D PCD Jewel devices - in 22
consecutive patients (Pts). The 7219C has an "active can" and requires a
single right ventricular (RV) lead while the 7219D requires RV and superior
vena cava leads ± subcutaneous patch(es). The 7219C was implanted in 10
Pts and the 72190 in 12 Pts. Polarities were tested in random order. The
results were:
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Of the 10 Pts receiving a 7219C device, 7 had lower DFT with RV+ while
in 3 lead polarity had no effect. Of the 12 Pts receiving a 7219D device, 7 had
lower DFT with RV+, 2 had lower DFT with RV-, and in 3 lead polarity had
no effect. Overall, with RV+ there was a 39% reduction in DFT for Model
7219C and a 31% reduction for Model 72190. An implant criterion of DFT
~24J was met in 21 Pts using either RV+ or RV-. In one Pt, however, the
OFT for RV- was 34J and for RV+ was 12J.
Conclusion: In this series, the lowest DFT was achieved most often using
the RV+ polarity. These results suggest that both RV lead polarities should
be tested to achieve the lowest OFT in Pts receiving a pectorally implanted
ICD.
'Refers to the polarity of the initial pulse deflection
treatment OFT values as percent of baseline. In the MS groups, the change
in OFT from Base to L was 92 ± 28% vs the change from Base to D5W of
0.6 ± 29% (p < 0.0001). In the BS groups, however, the change in DFT from
Base to L was similar to the change from Base to D5W (-6.7 ± 15 vs -29 ±
17%, p = 0.08). Compared to D5W, L increased DFT in the biphasic group by
a magnitude that was *that seen in the monophasic group. Clinical Impli-
cations: The effect of antiarrhythmic drugs on DFT (especially increased DFT
values) may be less of a concern when using implantable devices employing
biphasic waveforms.
LA± SQ/SM LA (all) LA 0062 LA 0064
N 345 230 32 198
Left approach 99 ± 4.8 10.1 ± 5.0 106± 61 101 ±4.8
Right approach 14.0 ± 7.3 146 ± 6.6 15.0 ± 00 145 ± 7.3
P value 0.02 <0.01 0.13 004
Conclusion: Nonthoracotomy ICD leads implanted from the right yield
higher biphasic DFTs than those implanted from the left confirming the im-
portant influence that lead position and vector have on the DFT.
Because the defibrillation threshold (OFT) is related to the vector of energy
delivery and amount of myocardium included in the shock field, we hypoth-
esized that implantable defibrillator (ICD) leads implanted from the right side
would yield higher DFTs than those implanted from the left. The database of
the Endotak lead trial using a biphasic ICO (P2, CPI) was used to determine
if the OFT depended on the site of venous access. The lead is a tripolar en-
docardiallead capable of bipolar sensing and pacing, and defibrillation using
the lead alone (LA). The most commonly used models were the 0062 and
0064 leads (13 and 16 em between the two defibrillation electrodes, respec-
tively). The lead may be also linked to a subcutaneous/submuscular patch
electrode (SO/SM) using a V-connector. Lead placement data were available
from 595 (97.5%) of the 610 patients (pts) in the trial, and of those 345 (58%)
had the DFT, defined as the lowest energy that was successful in terminat-
ing ventricular fibrillation, determined by a step-down protocol. There were
274 males and 71 females, with a mean age of 61 ± 13 years, and LVejec-
tion fraction (LVEF) 0.33 ± 0.13. The cardiac disease was ischemic in 247 pts
(72%), nonischemic cardiomyopathy in 74 pts (21 %), and other etiologies in
the rest. The endocardial lead was implanted from the left in 324 pts (93.9%)
and the right in 21 pts (6.1 %). There were no differences between the two
groups with respect to gender, age, LVEF, or underlying cardiac disease. The
mean DFTs (joules) were:
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Antiarrhythmic drugs can interfere with electrical defibrillation using
monophasic non-sequential shocks (MS). It is unknown if these drugs affect
the efficacy of biphasic defibrillation shocks (BS). Since MS and BS wave-
forms can exhibit disparate effects on myocardial excitability and refractori-
ness (properties which may influence defibrillation efficacy), it is possible that
antiarrhythmic drugs, such as lidocaine (L), will affect defibrillation threshold
(OFT) of one waveform differently than another. We studied 25 pentobarbi-
tal anesthetized farm swine who had endocardial pacing and monophasic
action potential catheters placed into the right ventricle. Pacing was used
to induced sustained ventricular fibrillation (5-8 s) which was followed by
defibrillation via epicardial electrodes. Each pig was assigned to one of four
treatment groups; 1) MS + D5W (n = 7), 2) MS + L (n = 7) 3) BS + 05W (n
= 5), or 4) BS + L (n = 7). DFTs were measured at baseline (Base) and sub-
sequently during treatment (D5W or L). DFT values (joules) predicting 50%
success at baseline were: MS + D5W = 7.34 ± 1.59, MS + L = 7.11 ± 1.5,
BS + D5W = 5.28 ± 1.55 and BS + L = 3.86 ± 1.2. The figure depicts
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Unstable Angina: The Plaque and the Artery
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We performed a histologic analysis of coronary lesions obtained by direc-
tional atherectomy from 100 patients with stable, unstable and evolving
angina pectoris. Histologic analysis was performed by two pathologists un-
aware of the clinical history or angiographic findings. This included notation
of the presence or absence of various matrix components and quantitative
scoring (0-3+) of cellular lesion components. Forty-seven patients (47%) had
native coronary lesions. Twenty-five patients (25%) had restenosis after pre-
vious balloon angioplasty and twenty-eight (28%) were treated for primary
saphenous vein graft disease. There were no differences in the average his-
tologic appearance of atherosclerotic lesions resulting in stable, unstable
and evolving angina pectoris. Saphenous vein graft lesions were typically
rich in dense connective tissue and extracellular lipid and mononuclear infil-
trate. Restenosis lesions were rich in acid mucopolysaccharide and vascular
smooth muscle cells and revealed no histologic differences according to the
clinical syndrome. Native coronary artery lesions, from patients with unsta-
ble angina, more often contained organizing thrombi (30% vs 0%, P < 0.05),
cholesterol crystals (20% vs 0%, P < 0.05) and harbored a more intense vas-
cular smooth muscle cell infiltrate (2.1 vs 1.4, P < 0.05) when compared to
lesions from patients with stable angina pectoris. There was no difference
